SUMMER RHODES: Open Payments
NPI 1699306290 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 62 payments from 13 companies in 2025. Trend: 2023 $1,268 · 2024 $821 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $320 |
| Vanda Pharmaceuticals Inc. | 10 | $253 |
| Janssen Pharmaceuticals, Inc | 5 | $196 |
| Axsome Therapeutics, Inc. | 17 | $189 |
| Alkermes, Inc. | 3 | $70 |
| ABBVIE INC. | 4 | $69 |
| Lundbeck LLC | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
Products named: CAPLYTA, SPRAVATO, Auvelity, FANAPT, HETLIOZ, VRAYLAR, REXULTI, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
